EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Enriched Metabolic Phenotyping Refines Phenotypic Resolution of Type 2 Diabetes

Min Wang, Yang Ou, Heng Su, Bing Zhang, Ben Niu, Anwar Ahmed, Guoqiang Xing iD

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.70866 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Min Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Science and Technology, Yunnan University, Kunming, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Yunnan Province Fuwai Cardiovascular Hospital Institutional Project, Open Project Grant for Clinical Medical Center of Yunnan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Data‐driven clustering studies of type 2 diabetes (T2D) based on limited routine clinical variables have reproducibly described major metabolic subgroups, including severe insulin‐deficient diabetes (SIDD), severe insulin‐resistant diabetes (SIRD), mild obesity‐related diabetes and mild age‐related diabetes. We examined whether deeper metabolic phenotyping can improve phenotypic resolution beyond these low‐dimensional frameworks.

Methods

We performed an exploratory cross‐sectional clustering analysis in 94 adults with newly diagnosed T2D and complete data, drawn from an initial 97 screened participants who underwent deep metabolic phenotyping. Principal component analysis (PCA) guided selection of 13 relatively independent variables spanning six physiological domains: glycaemic exposure, insulin sensitivity and secretion, visceral adiposity, lipid metabolism, skeletal muscle status, hepatic injury and haematological indices. K‐means clustering was applied to standardised variables. Robustness was assessed across prespecified 5‐, 9‐ and 13‐variable panels, exclusion of age, alternative muscle and adiposity representations and comparison with hierarchical and Gaussian mixture clustering. Autoimmune diabetes was not examined due to insufficient case numbers.

Results

Five phenotypic clusters were observed, including preserved insulin sensitivity with compensatory hyperinsulinaemia (IS‐HI). Two clusters aligned with canonical SIDD‐like and SIRD‐like phenotypes. Within the enriched model, two additional physiologically coherent patterns were resolved: a myogenic–anaemia phenotype (MA), characterised by reduced skeletal muscle percentage and altered haematological indices and a hepato‐lipotoxic phenotype (HL), marked by dyslipidaemia and elevated hepatic enzymes. In an unconstrained sensitivity rerun of the same 13‐variable panel, however, a distinct SIDD‐like cluster did not re‐emerge, underscoring that higher‐dimensional clustering depends in part on variable selection and biologically anchored interpretation. Internal robustness analyses supported preservation of the overall cluster architecture across variable panels, although alternative clustering methods yielded non‐identical partitions.

Conclusions

Phenotypic depth may improve the mechanistic resolution of type 2 diabetes beyond routine‐variable frameworks. However, the present single‐centre findings are hypothesis‐generating only, do not support clinical decision‐making and all treatment‐related inferences remain speculative without longitudinal outcome data and external validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2HumansPhenotypeFemaleCross-Sectional StudiesInsulin ResistanceMaleMiddle AgedCluster AnalysisClustering AlgorithmsPrincipal Component AnalysisAgedAdultData AnalyticsMuscle, Skeletal

Stichwörter der Autor:innen

data‐driven clusteringdeep metabolic phenotypinginsulin secretionprecision medicineskeletal muscletype 2 diabetesvisceral adiposity

Autor:innen und Institutionen

  • School of Chemical Science and Technology, Yunnan University, Kunming, China.
  • Department of Endocrinology, The First People's Hospital of Yunnan Province, Kunming, China.
  • Department of Medicine, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.
  • Clinical Laboratory, The Affiliated Hospital and the Second Clinical Medical College of North Sichuan Medical University, Nanchong Central Hospital, Nanchong, China.
  • Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
  • Lotus Biotech.com LLC, Gaithersburg, Maryland, USA.

ORCID-Profile: Guoqiang Xing

Förderung

  • Yunnan Province Fuwai Cardiovascular Hospital Institutional Project
  • Open Project Grant for Clinical Medical Center of Yunnan Province

Zitieren

APA

Wang, M., Ou, Y., Su, H., Zhang, B., Niu, B., Ahmed, A., & Xing, G. (2026). Enriched Metabolic Phenotyping Refines Phenotypic Resolution of Type 2 Diabetes. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70866

Vancouver

Wang M, Ou Y, Su H, Zhang B, Niu B, Ahmed A, et al. Enriched Metabolic Phenotyping Refines Phenotypic Resolution of Type 2 Diabetes. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70866

BibTeX
@article{Wang2026,
  author = {Wang, Min and Ou, Yang and Su, Heng and Zhang, Bing and Niu, Ben and Ahmed, Anwar and Xing, Guoqiang},
  title = {Enriched Metabolic Phenotyping Refines Phenotypic Resolution of Type 2 Diabetes},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70866}
}
Kostenlos starten →